| Metric | Q3 FY26 | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Other income | 0.0 | 0.3 | 0.3 |
| Total income | 0.0 | 0.3 | 0.3 |
| Net profit | -0.1 | 0.1 | 0.1 |
| Operating margin | 0.0% | 66.7% | 66.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, BSE: 540159. Figures extracted from the filing.
Purple Agrotech Industries Ltd: key numbers
- Share price
- ₹6.08
- Market cap
- ₹5.26 Cr
- Revenue (annual)
- ₹20.00 Cr
- Net profit (annual)
- ₹0.16 Cr
- P/E (TTM)
- 54.9×Sector 26.9×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Purple Agrotech Industries Ltd
All →Purple Agrotech Industries Legal & Regulatory
Purple Agrotech Industries received a BSE advisory letter concerning past non-compliance with Regulation 45(3) during its name change. The company reports no material financial impact.
Purple Agrotech Industries Annual General Meeting
Purple Agrotech Industries Ltd conducted its 52nd Annual General Meeting on 25th September, 2026, transacting various ordinary and special business items.
Purple Agrotech Industries Capital Structure Change
Sanjeev Lunkad and PACs sold 40,000 shares of Purple Agrotech in the open market. Their stake fell from 5.22% to 4.76%, crossing below the 5% threshold.
Purple Agrotech Industries Annual Report
Purple Agrotech Industries Limited has submitted its 52nd Annual Report for FY 2025-26. The Annual General Meeting is scheduled for September 25, 2026, via video conferencing.
Purple Agrotech Industries Annual General Meeting
Purple Agrotech Industries Limited has issued a notice for its 52nd Annual General Meeting scheduled for September 25, 2026. The meeting will address seven agenda items.
Purple Agrotech Industries Board Meeting Outcome
Purple Agrotech Industries' board approved the 52nd AGM convening, director re-appointments, and the appointment of Naishadh Dineshbhai Modi as MD and CFO.